SD
INSIDER · TLX · Telix Pharmaceuticals Ltd · GROUP CHIEF FINANCIAL OFFICER
Smith Darren Charlton
Every open-market transaction filed under this name, Sep 7 to Sep 7.
Filings
1
1 buy · 0 sells
Bought
$20K
open market, at cost
Sold
—
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 7 | TLX | Telix Pharmaceuticals Ltd | Group Chief Financial Officer | Buy | 2,071 | $9.66 | $20K | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.